Skip to content

The impact of 15-minutes versus 2 hours preoperative supine time in day-surgery mode to the diagnostic efficacy of adrenal venous sampling: A single-center prospective randomized controlled study

The impact of 15-minutes versus 2 hours preoperative supine time in day-surgery mode to the diagnostic efficacy of adrenal venous sampling: A single-center prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112336
Enrollment
Unknown
Registered
2025-11-12
Start date
2023-03-29
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary aldosteronism

Interventions

15-min supine group:Lie flat for 15 minutes before surgery
2-hours supine group:Lie flat for 2 hours before surgery

Sponsors

The second affiliated hospital of Zhejiang University school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients are clinically diagnosed as primary aldosteronism ; 2. Patients with willing for AVS; 3. Age 18 or above, male or female, with legal capacity.

Exclusion criteria

Exclusion criteria: 1. Patients with suspected adrenocortical carcinoma or pheochromocytoma; 2. Patients don’t accept or with high risk of adrenal surgery; 3. Patients have been subtyping to glucocorticoid-suppressible hyperaldosteronism or familial hyperaldosteronism type III; 4. Patients were diagnosed as Cushing syndrome or subclinical Cushing syndrome; 5. Patients were treated with glucocorticoids recently; 6. Patients with whole body or venipuncture area infection; 7. Patients with venous access thrombosis; 8. Patients are allergic to iodine; 9. Patients with X-ray contraindications; 10. Patients with coagulation dysfunction; 11. Patients are unable to cooperate and follow-up.

Design outcomes

Primary

MeasureTime frame
biochemical remission rate;

Secondary

MeasureTime frame
clinical remission rate;the change of blood pressure;The success rate of cannulation;The daily defined dose of hypertensive agents;

Countries

China

Contacts

Public ContactZhenjie Liu

The second affiliated hospital of Zhejiang University school of medicine

lawson4001@zju.edu.cn+86 571 86807897

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026